GHTM

Global Health and Tropical Medicine

  • GHTM
    • About GHTM
    • Governance
    • Impact
    • Members
      • Population health, policies and services
        • PPS PhD members
        • PPS non PhD members
      • TB, HIV and opportunistic diseases and pathogens
        • THOP PhD members
        • THOP non PhD members
      • Vector-borne diseases
        • VBD PhD members
        • VBD non PhD members
      • Individual Health Care
        • IHC PhD members
        • IHC non PhD members
      • Tech & Admin support
    • Scientific Advisory Board
  • Research
    • Cross-cutting issues
      • Global Pathogen Dispersion and Population Mobility
      • Drug Discovery and Drug Resistance
      • Diagnostics
      • Public Health Information
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • THOP – TB, HIV and opportunistic diseases and pathogens
      • VBD – Vector borne diseases
      • IHC – Individual health care
    • Research in numbers
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
    • Projects
      • Ongoing Projects
      • Completed Projects
  • Outreach
    • Events
    • News
    • Policy Support & Community Outreach
  • Publications
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
  • Capacity Building
    • Education
      • Master Theses
      • PhD Theses
    • International
  • Infrastructures
  • Networks & Partnerships
  • Reports
    • GHTM
    • Scientific Advisory Board
    • FCT
Home / Archives for 2021

Determinants of COVID-19 Vaccine Hesitancy in Portuguese-Speaking Countries: A Structural Equations Modeling Approach

  • Authors: Álvaro Francisco Lopes de Sousa, Jules Ramon Brito Teixeira, Iracema Lua, Fernanda de Oliveira Souza, Andrêa Jacqueline Fortes Ferreira, Guilherme Schneider, Herica Emilia Félix de Carvalho, Layze Braz de Oliveira, Shirley Verônica Melo Almeida Lima, Anderson Reis de Sousa, Telma Maria Evangelista de Araújo, Emerson Lucas Silva Camargo, Mônica Oliveira Batista Oriá, Isabel Craveiro, Tânia Maria de Araújo, Isabel Amélia Costa Mendes, Carla Arena Aparecida Ventura, Isabel Sousa, Rodrigo Mota de Oliveira, Manuel Simão, Inês Fronteira
  • Publication Year: 2021
  • Journal: Vaccines, vol 9, art 1167
  • Link: https://www.mdpi.com/2076-393X/9/10/1167

COVID-19 vaccine hesitancy (VH) has caused concerns due to the possible fluctuations that may occur directly impacting the control of the pandemic. In this study, we aimed to estimate the prevalence and factors associated with COVID-19 VH in Portuguese-speaking countries.
Read More

Targeting malaria protein kinases

  • Authors: Tatyana Almeida Tavella, Gustavo Capatti Cassiano, Marilia N Nascimento, Daniel Alencar Rodrigues, Pedro Vítor Lemos Cravo, Carolina Horta Andrade, Fabio Trindade Maranhão Costa
  • Publication Year: 2021
  • Journal: Advances in Protein Chemistry and Structural Biology, vol 124, pp 225-274
  • Link: https://doi.org/10.1016/bs.apcsb.2020.10.004

CHAPTER 7 OF THE BOOK «PROTEIN KINASES IN DRUG DISCOVERY»   ABSTRACT Malaria is one of the most impacting public health problems in tropical and subtropical areas of the globe, with approximately 200 million cases worldwide annually. In the absence of an effective vaccine, rapid treatment is vital for effective malaria control. However, parasite resistance […]
Read More

Yeast-based high-throughput screens for discovery of kinase inhibitors for neglected diseases

  • Authors: Tatyana Almeida Tavella, Gustavo Capatti Cassiano, Fabio Trindade Maranhão Costa, Per Sunnerhagen, Elizabeth Bilsland
  • Publication Year: 2021
  • Journal: Advances in Protein Chemistry and Structural Biology, vol 124, pp 275-309
  • Link: https://doi.org/10.1016/bs.apcsb.2020.09.007

CHAPTER 8 OF THE BOOK «PROTEIN KINASES IN DRUG DISCOVERY»   ABSTRACT The discovery and development of a new drug is a complex, time consuming and costly process that typically takes over 10 years and costs around 1 billion dollars from bench to market. This scenario makes the discovery of novel drugs targeting neglected tropical […]
Read More

Whole-genome sequencing as a tool for studying the microevolution of drug-resistant serial Mycobacterium tuberculosis isolates

  • Authors: Jaciara de Lourdes do Carmo Guimarães Diniz, Andrea von Groll, Gisela Unis, Elis Regina Dalla Costa, Maria Lucia Rosa Rossetti, Júlia Silveira Vianna, Daniela Fernandes Ramos, Ana Júlia Reis, Priscila Cristina Bartolomeu Halicki, João Luis Rheingantz Scaini, Yasmin Castillos de Ibrahim das Neves, Jody Phelan, Ana Rita Gomes, Susana Campino, Karina dos Santos Machado, Adriano Velasque Werhli, Arnab Pain, Taane Gregory Clark, João Perdigão, Miguel Viveiros, Isabel Portugal, Pedro Eduardo Almeida Silva
  • Publication Year: 2021
  • Journal: Tuberculosis, vol 131, art 102137
  • Link: https://doi.org/10.1016/j.tube.2021.102137

ABSTRACT Treatment of drug-resistant tuberculosis requires extended use of more toxic and less effective drugs and may result in retreatment cases due to failure, abandonment or disease recurrence. It is therefore important to understand the evolutionary process of drug resistance in Mycobacterium tuberculosis. We here in describe the microevolution of drug resistance in serial isolates from six previously […]
Read More

Wide and increasing suitability for Aedes albopictus in Europe is congruent across distribution models

  • Authors: Sandra Oliveira, Jorge Rocha, Carla A. Sousa, César Capinha
  • Publication Year: 2021
  • Journal: Scientific Reports, vol 11, art 9916
  • Link: https://doi.org/10.1038/s41598-021-89096-5

ABSTRACT The Asian tiger mosquito (Aedes albopictus), a vector of dengue, Zika and other diseases, was introduced in Europe in the 1970s, where it is still widening its range. Spurred by public health concerns, several studies have delivered predictions of the current and future distribution of the species for this region, often with differing results. […]
Read More

  • 1
  • 2
  • 3
  • …
  • 29
  • Next Page »

About GHTM

GHTM is a R&D Unit that brings together researchers with a track record in Tropical Medicine and International & Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal

+351 213 652 600

  • E-mail
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Map

  • Events
  • Research Groups
  • Cross-cutting issues
© Copyright 2025 IHMT-UNL All Rights Reserved.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    UIDB/04413/2020
    UIDP/04413/2020

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok